Vistakon launches professional development group

Article

Vistakon has created a new professional development group that combines its professional affairs, ODLean consulting program, and optometry school educational efforts into one department.

Jacksonville, FL-Vistakon, a division of Johnson & Johnson Vision Care Inc., has created a new professional development group that combines its professional affairs, ODLean consulting program, and optometry school educational efforts into one department.
 

  • Damian May, PharmD, MBA, has been appointed senior director, Strategy & Professional Development, responsible for working with the new organization to set the vision, strategy and roadmap for the Group to meet the changing demands of the optometric marketplace.

  • Dick Wallingford, OD, has been named senior director, Professional Affairs. In this expanded role, Dr. Wallingford will continue to lead the company’s professional affairs activities with associations and eye care practitioners, as well as oversee management of its Optometry School programs.

  • W. Lee Ball, OD, FAAO, will continue to work with Dr. Wallingford to support these efforts.
     

Said Dave Brown, Vistakon president: “Under Damian and Dick’s proven leadership, we believe we are well poised to help current and future optometrists prepare for and readily adapt to a complex and fast-changing healthcare environment.”

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.